Cargando…

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis

BACKGROUND: Moyamoya disease (MMD) is a leading cause of stroke in children and young adults, whereas no specific drugs are available. Antiplatelet therapy (APT) has been considered a promising treatment option, but its effectiveness remains controversial. Therefore, we aimed to comprehensively eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tingting, Qin, Mingzhen, Xiong, Xuejiao, Li, Tingting, Feng, Luda, Lai, Xinxing, Gao, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318533/ https://www.ncbi.nlm.nih.gov/pubmed/37409015 http://dx.doi.org/10.3389/fneur.2023.1132339

Ejemplares similares

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Multi-omics approaches for deciphering the complexity of traditional Chinese medicine syndromes in stroke: A systematic review
por: Liu, Tingting, et al.
Publicado: (2022)

Efficacy and safety of edaravone for acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis
por: Feng, Luda, et al.
Publicado: (2020)

Platelet-activating factor receptor antagonists of natural origin for acute ischemic stroke: a systematic review of current evidence
por: Li, Tingting, et al.
Publicado: (2022)

Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
por: Pang, Chang Hwan, et al.
Publicado: (2021)

Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis
por: Cao, Jun, et al.
Publicado: (2023)

Edaravone use in acute intracerebral hemorrhage: A systematic review and meta-analysis of randomized controlled trials
por: Qin, Mingzhen, et al.
Publicado: (2022)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China
por: Ye, Fei, et al.
Publicado: (2021)

Antiplatelet vs. Anticoagulation in Cervical Artery Dissection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Liu, Sihua, et al.
Publicado: (2021)

Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials
por: Shi, Xinyi, et al.
Publicado: (2023)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

Effects of Prior Antiplatelet Therapy on Mortality, Functional Outcome, and Hematoma Expansion in Intracerebral Hemorrhage: An Updated Systematic Review and Meta-Analysis of Cohort Studies
por: Wu, Yujie, et al.
Publicado: (2021)

Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm
por: Yang, Ri-Miao, et al.
Publicado: (2023)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
por: Zhang, Xin, et al.
Publicado: (2022)

The Impact of Preinjury Use of Antiplatelet Drugs on Outcomes of Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Cheng, Li, et al.
Publicado: (2022)

Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Non-invasive Urinary Biomarkers in Moyamoya Disease
por: Sesen, Julie, et al.
Publicado: (2021)

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Western Moyamoya Phenotype: A Scoping Review
por: Miller, Raphael, et al.
Publicado: (2021)

Surgical Management of Failed Revascularization in Moyamoya Vasculopathy
por: Lucia, Kristin, et al.
Publicado: (2021)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Comparing the Effectiveness of Intravenous Tissue Plasminogen Activator and Dual Antiplatelet Therapy in Patients With Minor Stroke: A Meta-Analysis
por: Monday, Obinna, et al.
Publicado: (2023)

Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report
por: Rosafio, Francesca, et al.
Publicado: (2021)

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

The relationship between hemoglobin and triglycerides in moyamoya disease: A cross-sectional study
por: Su, Yu, et al.
Publicado: (2022)

Characterization of Inpatient Moyamoya in the United States: 1988–2004
por: Lee, Darrin J., et al.
Publicado: (2011)

Moyamoya Disease in a Six Month Caucasian Female
por: Moore, Faith D, et al.
Publicado: (2020)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Corrigendum: Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0u7f5f7qf97lso9ve6383pthkq